NKMax Co Ltd
KOSDAQ:182400
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Getein Biotech Inc
SSE:603387
|
CN |
NKMax Co Ltd
Inventory
NKMax Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NKMax Co Ltd
KOSDAQ:182400
|
Inventory
₩567.8m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-16%
|
|
|
Celltrion Inc
KRX:068270
|
Inventory
₩2.8T
|
CAGR 3-Years
66%
|
CAGR 5-Years
49%
|
CAGR 10-Years
28%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Inventory
₩396.7m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Inventory
₩6.5B
|
CAGR 3-Years
61%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
NKMax Co Ltd
Glance View
NKMAX Co., Ltd. engages in the development, manufacture, and sale of recombinant proteins and monoclonal antibodies. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2015-10-23. The firm is involved in the production and sale of recombinant proteins, monoclonal antibodies, NK cell activity test kits, cell therapy products, and in the provision of other related services. The NK cell activity test kits are provided under the name of NK Vue. The firm distributes its products within domestic market and to overseas markets.
See Also
What is NKMax Co Ltd's Inventory?
Inventory
567.8m
KRW
Based on the financial report for Dec 31, 2025, NKMax Co Ltd's Inventory amounts to 567.8m KRW.
What is NKMax Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
-16%
Over the last year, the Inventory growth was 9%. The average annual Inventory growth rates for NKMax Co Ltd have been -44% over the past three years , -32% over the past five years , and -16% over the past ten years .
